U.S. regulators approved Roche AG's request to market antiviral drug Tamiflu for preventing influenza in children ages 1 through 12, the company said on Wednesday.
Tamiflu is being stockpiled by countries in case of an avian flu pandemic in people. The drug previously was approved for preventing infection in adults and adolescents age 13 and older and for treating the flu in anyone 1 year old or older.